SCHEMBL741609

SCHEMBL741609

COc1ccc(C(=O)Nc2n[nH]c3sc(C(=O)NC(C)(C)c4ccccc4)cc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.52
ABL1 P00519 2/20 0.50
BCR P11274 2/20 0.50
HDAC6 Q9UBN7 3/20 0.46
ADORA3 P0DMS8 3/20 0.43
CDK7 P50613 1/20 0.43
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
ADORA1 P30542 1/20 0.41
KDR P35968 1/20 0.41
MAPKAPK2 P49137 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779927 0.94 RXFP1 (0.49) AURKAABL1BCRHDAC6NPC1
SCHEMBL739779 0.93 AURKA (0.52) AURKAABL1BCRHDAC6ROCK2
SCHEMBL740292 0.91 AURKA (0.55) AURKAABL1BCRHDAC6CDK7
SCHEMBL740599 0.91 AURKA (0.49) AURKAABL1BCRHDAC6ADORA3
SCHEMBL741311 0.89 AURKA (0.53) AURKAABL1BCRHDAC6ADORA3
SCHEMBL738866 0.89 AURKA (0.53) AURKAABL1BCRHDAC6CDK7
SCHEMBL2418757 0.88 HDAC6 (0.50) AURKAHDAC6ADORA3CDK7MAPT
SCHEMBL740809 0.88 AURKA (0.52) AURKAABL1BCRHDAC6CDK7
SCHEMBL741896 0.87 RAB9A (0.47) AURKAABL1MAPTSMN1; SMN2NPC1
SCHEMBL741926 0.87 AURKA (0.52) AURKAABL1BCRHDAC6CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed